Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites
Abstract
Malaria is caused by Plasmodium parasites and remains a significant health concern for almost half the world's population. There are estimated to be > 240 million malaria cases and approximately 600,000 malaria-related deaths annually, mainly due to infection with P. falciparum parasites. Parasite drug resistance is impacting malaria prevention and control efforts, and as part of the malaria eradication agenda, new drugs with novel mechanisms of action are needed. Histone/lysine deacetylase (HDAC) enzymes play essential roles in Plasmodium biology and are potential targets for the development of new antiplasmodial agents. In this study, a panel of 24 HDAC inhibitors with hydroxamic acid zinc binding group, a pentyloxyamide connecting unit linker region and substituted 4-phenyl and 4(pyridinyl)thiazole cap groups were investigated for in vitro activity against asexual intraerythrocytic stage P. falciparum parasites, the life cycle stage responsible for the clinical symptoms of malaria. The most potent compound (4o) had a P. falciparum IC50 of 20 nM and >250-fold greater selectivity for P. falciparum versus human cells. Compound 4o was also active against exoerythrocytic stage parasites (IC50 24 nM), which are a target for malaria prevention. In contrast, 4o lacked potent activity against late-stage gametocytes (IC50 > 2 μM), which are a target for malaria transmission-blocking drugs. Compound 4o and analogues caused in situ hyperacetylation of P. falciparum histone H4,…
Read the paper
Related studies
- Diagnosis and management of glutaric aciduria type I – revised recommendations
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency
- Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry
- Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
- Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.